微芯生物(688321.SH)发布半年度业绩，归母净利润2959万元，同比扭亏为盈

Group 1 - The company reported a revenue of 407 million yuan for the first half of 2025, representing a year-on-year growth of 34.56% [1] - The net profit attributable to the parent company was 29.59 million yuan, marking a turnaround from a loss to profit compared to the previous year [1] - The non-recurring net profit was 20.32 million yuan, also indicating a recovery from a loss year-on-year [1] - The basic earnings per share were 0.0726 yuan [1]